Allergan announces intent to file eyelash stimulant with FDA
IRVINE, Calif. Allergan announced today that it intends to file an application with the Food and Drug Administration for bimatoprost, a synthetic prostaglandin analog, as a treatment to stimulate eyelash growth, by end of the third quarter of 2008 after receiving promising results from a clinical trial.
“Our exploration of bimatoprost as an eyelash growth enhancer reflects our continuing commitment to offer innovative medical aesthetic treatments that are science-based, with the clinically proven safety and efficacy that consumers have come to trust Allergan to provide,” said Scott Whitcup, Allergan’s executive vice president, research and development. “We are pleased with the results of our clinical program and believe this innovative product, if approved, could meet a significant and currently unmet demand in the medical aesthetic marketplace.”
According to Allergan, the global mascara market is presently estimated to be $3.7 billion annually. Allergan currently anticipates the product to be approved by the FDA in 2009 and to have annual sales that exceed $500 million.
Flaherty to become official cfo at Sally Beauty
After two months as acting chief financial officer of Sally Beauty Holdings, Mark Flaherty will become its chief financial officer and senior vice president, Sally announced Thursday.
Prior to his stint as acting chief financial officer, Flaherty had served as vice president, chief accounting officer and controller since October 2007. He previously had worked at Tandy Brands Accessories as chief financial officer from August 2002 to October 2007.
In his new role at Sally, Flaherty will be responsible for accounting, payroll and benefits, treasury and risk management, finance, tax, investor relations strategic planning and loss prevention.
Based in Denton, Texas, Sally Beauty Holdings is an international retailer and distributor of beauty products. It distributes and sells products throughout North America and Europe, as well as in Japan.
Dadario appointed Bare Escentuals president of retail
SAN FRANCISCO Bare Escentuals, a maker of mineral makeup, has appointed Michael Dadario as president of retail, responsible for Bare Escentuals’ overall retail strategy and execution including merchandising, sales and operations for all domestic brick-and-mortar distribution channels.
Dadario will report to Leslie Blodgett, chief executive officer of Bare Escentuals.
Dadario comes to Bare Escentuals with more than 30 years of retail operations experience at companies including J. Crew, Inc. and Gap. Most recently, he was senior vice president of stores for Williams-Sonoma, where he was responsible for establishing the retail strategies for the company’s emerging Williams-Sonoma Home and west elm brands.
Dadario also spent a year teaching marketing at the Fashion Institute of Design & Marketing (FIDM) and served five years as president of the San Francisco AIDS Health Project.